Kynam Capital Management, LP Dynavax Technologies Corp Call Options Transaction History
Kynam Capital Management, LP
- $1.22 Billion
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding DVAX
# of Institutions
271Shares Held
131MCall Options Held
421KPut Options Held
149K-
Black Rock Inc. New York, NY21.9MShares$296 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.5MShares$169 Million5.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.22MShares$125 Million0.0% of portfolio
-
State Street Corp Boston, MA7.69MShares$104 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA5.61MShares$75.8 Million0.14% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.71B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...